Omaveloxolone Activates Nrf2 and Inhibits NF-κB for Friedreich’s Ataxia Research
Omaveloxolone (RTA 408) is an agent for Friedreich's Ataxia. And it acts through a combination of activation of the antioxidative transcription factor Nrf2 and inhibition of the pro-inflammatory transcription factor…